Your browser doesn't support javascript.
loading
A novel household-based patient outreach pilot program to boost late-season influenza vaccination rates during the COVID-19 pandemic.
Fisher, Lloyd; Loiacono, Matthew M; Payne, Nick; Kelley, Tina; Greenberg, Michael; Charpentier, Mary; Leblanc, Candace; Sundaresan, Devi; Bancroft, Tim; Steffens, Andrea; Paudel, Misti.
Afiliação
  • Fisher L; Reliant Medical Group, Worcester, Massachusetts, USA.
  • Loiacono MM; UMass Medical School, Worcester, Massachusetts, USA.
  • Payne N; Sanofi, Swiftwater, Pennsylvania, USA.
  • Kelley T; Optum Life Sciences, Eden Prairie, Minnesota, USA.
  • Greenberg M; Optum Life Sciences, Eden Prairie, Minnesota, USA.
  • Charpentier M; Sanofi, Swiftwater, Pennsylvania, USA.
  • Leblanc C; Reliant Medical Group, Worcester, Massachusetts, USA.
  • Sundaresan D; Reliant Medical Group, Worcester, Massachusetts, USA.
  • Bancroft T; Reliant Medical Group, Worcester, Massachusetts, USA.
  • Steffens A; Optum Life Sciences, Eden Prairie, Minnesota, USA.
  • Paudel M; Optum Life Sciences, Eden Prairie, Minnesota, USA.
Influenza Other Respir Viruses ; 16(6): 1141-1150, 2022 11.
Article em En | MEDLINE | ID: mdl-36098249
BACKGROUND: The objective of this study was to test a novel household-based approach to improve late-season influenza vaccine uptake during the 2020-2021 season, using Epic's MyChart patient portal messages and/or interactive voice response telephone calls. METHODS: This study was a non-blinded, quality improvement program using a block randomized design conducted among patients from Reliant Medical Group clinics residing in a traditional household (≥2 individuals clinically active in the Reliant system living at the same address). Households were randomized 1:1:1 into intervention arms: non-tailored communication (messaging based on CDC's seasonal influenza vaccination campaign), tailored communication (comprehensive communication including reinforcement of the importance of influenza vaccination for high-risk individuals), and standard-of-care control. Influenza vaccination during the program was captured via medical records, and the odds of vaccination among communication arms versus the control arm were assessed. A survey assessing influenza vaccination drivers was administered using MyChart. RESULTS: Influenza vaccination increased by 3.3% during the program period, and no significant differences in vaccination were observed in intervention arms relative to the control arm. Study operationalization faced substantial challenges related to the concurrent COVID-19 pandemic. Compared with vaccinated survey respondents, unvaccinated respondents less frequently reported receiving a recommendation for influenza vaccination from their healthcare provider (15.8% vs. 42.3%, p < 0.001) or awareness that vaccination could protect themselves and higher risk contacts (82.3% vs. 92.6%, p < 0.001). CONCLUSIONS: No significant effects of the interventions were observed. Survey results highlighted the importance of healthcare provider recommendations and the need for increased education around the benefits of vaccination.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / COVID-19 Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / COVID-19 Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article